Global Health Progress applauds Japan for enhanced support to the Global Fund to Fight AIDS, Tuberculosis and Malaria

Statement by Dr. Paul Antony, medical advisor Global Health Progress

(Tokyo) - "The worldwide pharmaceutical industry applauds H.E. Mr. Yasuo Fukuda, Prime Minister of Japan and his government’s pledge for an additional US$560 million to the Global Fund to Fight AIDS, Tuberculosis and Malaria. The Global Fund’s work has been instrumental in the fight against the AIDS, TB and malaria, which claim six million lives annually and affect many more families and communities in the poorest countries of the world.

R&D Pharmaceutical Companies Mobilize to Help Victims of Natural Disasters in Burma and China

Industry Emergency Funding Assistance and Medicine Donations Already Exceed USD 17 Million

Geneva – The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) confirms that, as in previous major natural disasters, the R&D-based pharmaceutical industry has moved quickly to provide substantial assistance for the victims of the recent cyclone in Burma and earthquake in southern China.

Partnering to Prevent Hepatitis B

by Michael J. Nyenhuis, President, Medical Assistance Programs (MAP) International

The children waited in long lines outside the school building in Quito, Ecuador, many with their shirt sleeves already rolled up in anticipation of their hepatitis B vaccination. None of them seemed especially enthusiastic about the endeavor, however, and many of them cringed when it was their turn.

Global Health Progress Commemorates First Annual World Hepatitis Day

Worldwide collaboration promotes prevention and access to treatment

Global Health Progress, an initiative sponsored by the worldwide pharmaceutical industry, joins the global community in commemorating the first annual World Hepatitis Day today, and applauds the health care workers and organizations that contribute to preventing and treating hepatitis infections and educating people worldwide about the disease.

Call for Action on HIV TB: HIV TB Global Leaders Forum

Response by the companies of the worldwide research-based biopharmaceutical industry

We, the research-based biopharmaceutical industry,

Hudson Institute Publishes The Index of Global Philanthropy 2008

The Center for Global Prosperity (CGP) at the Hudson Institute has published The Index of Global Philanthropy 2008. This annual index provides details on the sources and magnitude of private giving to the developing world. The 2008 report shows continued growth of private giving and investment, which now accounts for over 75 percent of donor countries’ entire economic dealings with developing nations.

ART Spells Hope for Those Living with AIDS

by Dale Hanson Bourke

Lusaka, Zambia—Most of us view HIV/AIDS as statistical tsunami, a tidal wave of numbers so great we can hardly comprehend their significance.

Global Health Progress Initiative Commemorates World Malaria Day

Research-based biopharmaceutical companies work in partnership with others to fight the malaria epidemic

Despite being preventable and treatable, malaria continues to devastate communities in tropical regions throughout Latin America, Asia and Africa. According to the World Health Organization (WHO), the malaria epidemic causes debilitating disease in more than 500 million people worldwide and kills more than one million people each year - mostly infants, young children and pregnant women.

Defeating Malaria: A Question of How Soon, Not How

By Joelle Tanguy, Senior Vice President for Global Programs & Partnerships Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria

Worldwide Pharmaceutical Industry Launches Global Health Progress

Industry supports hundreds of programs helping millions in the developing
world and is looking for new partners

The worldwide pharmaceutical industry today launched Global Health Progress, an initiative to bring research-based biopharmaceutical companies, global health leaders and policymakers together to build on current partnerships to improve health in the developing world.

Pages